Evidence map›Paper›PMID 42737179›Full record

ArticlePolymers2026

Thermo-Reactively Coupled (TRC) HDPE for Melt-Processable Warp-Resistant FDM 3D Printing.

Subhaprad Ash, Muhammad Naveed, Muhammad Rabnawaz

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Subhaprad AshSchool of Packaging, Michigan State University, 448 Wilson Road, East Lansing, MI 48824, USA.ORCID 0000-0002-3816-1139
Muhammad NaveedSchool of Packaging, Michigan State University, 448 Wilson Road, East Lansing, MI 48824, USA.ORCID 0000-0003-0120-2029
Muhammad RabnawazSchool of Packaging, Michigan State University, 448 Wilson Road, East Lansing, MI 48824, USA.ORCID 0000-0002-4576-1810

Funding

U.S. National Science Foundation 2044877
6 · The paper itself

Abstract

Polyethylene, the most widely used and inexpensive commodity thermoplastic, remains unsuitable for 3D printing via fused deposition modeling (FDM) because of shrinkage-induced warping. Herein, this study aimed to develop a single-step reactive extrusion process to improve the filament-forming ability and 3D printability of high-density polyethylene (HDPE). HDPE was reacted with maleic anhydride, 1,10-decanediol, and a zinc acetate catalyst via peroxide-driven grafting in a melt extruder, and the subsequent coupling reactions yielded ester-containing, modified polyethylene structures. Unlike unmodified HDPE, which produced irregular filaments and poor 3D printing, the modified HDPE formulations produced filaments with a consistent diameter and enabled successful FDM printing with improved print quality. The optimized carbon-black-containing modified HDPE systems exhibited substantial mechanical improvements, with average enhancements of approximately 50-75% in tensile stress at break and an approximately 200% increase in elongation at break compared with neat HDPE. These results demonstrate that ester-containing HDPE has the potential to convert commodity HDPE into a melt-processable and mechanically improved feedstock for additive manufacturing applications. This study suggests that widely available post-consumer pigmented HDPE, which is otherwise unsuitable for reuse in packaging, could potentially be explored for 3D printing as an alternative to expensive acrylonitrile butadiene styrene (ABS) and polylactic acid (PLA).

Indexed as

3D printingadditive manufacturingester-linked interchainsfilament formationfused deposition modeling (FDM)melt-processablepolyethylenereactive extrusionthermo-reactively coupled (TRC)

Identifiers

PMID42737179
PMCPMC13568301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.